Search company, investor...

Founded Year



Growth Equity | Alive

About OpenClinica

OpenClinica is a company that provides clinical research solutions. It offers electronic data capture (EDC), electronic patient reported outcomes, reporting, randomization, and other solutions. The company was founded in 2004 and is based in Watham, Massachusetts.

Headquarters Location

1075 Main Street Suite #140

Waltham, Massachusetts, 02451,

United States

+1 617-621-8585


ESPs containing OpenClinica

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

Healthcare & Life Sciences / Drug R&D Tech

The randomization & trial supply management (RTSM) market provides a range of tools and software for managing clinical trials, including randomization and trial supply management. These systems can help ensure that clinical trials are conducted in a randomized and controlled manner, which is essential for producing reliable and unbiased results. RTSM systems can also help manage the distribution a…

OpenClinica named as Outperformer among 8 other companies, including Veeva Systems, 4G Clinical, and Slope.


Expert Collections containing OpenClinica

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

OpenClinica is included in 1 Expert Collection, including Digital Health.


Digital Health

10,804 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

OpenClinica Patents

OpenClinica has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics



Vaccines, Data management, Clinical research, Vaccination, NoSQL


Application Date


Grant Date


Related Topics

Vaccines, Data management, Clinical research, Vaccination, NoSQL



Latest OpenClinica News

OpenClinica Bolsters Decentralized Clinical Trials Toolkit

Sep 7, 2023

News provided by Share this article OpenClinica's DCT toolkit improves patient engagement, access and diversity NEEDHAM, Mass., September 7th, 2023 /PRNewswire-PRWeb/ -- OpenClinica debuts  eConsent , a complete digital consent solution for improved efficiency, access and patient engagement in clinical trials. OpenClinica Consent is an important addition to the company's decentralized clinical trials (DCT) toolkit, which also includes: OpenClinica ParticipateTM electronic patient reported outcomes (ePRO) and OpenClinica UniteTM, an  award-winning EHR to EDC integration technology that automates source data acquisition from EHRs and EMRs to clinical trial research databases (EDCs) and case report forms (eCRFs) at scale. "Clinical trials can easily integrate OpenClinica Consent with our family of patient engagement and DCT solutions to provide an end-to-end patient journey or use it as a standalone tool." "At OpenClinica, we have long been committed to helping sites and sponsors improve patient participation, engagement and diversity in clinical trials," said Ben Baumann, OpenClinica Co-Founder and Chief Operating Officer. "Clinical trials can easily integrate OpenClinica Consent with our family of patient engagement and DCT solutions to provide an end-to-end patient journey or use it as a standalone tool." In May 2023, the U.S. Food and Drug Administration released  new draft guidance to advance decentralized clinical trials. The draft guidance expands on the 2020 agency recommendations and is intended to "increase the breadth and diversity of participants in clinical trials and improve accessibility for those with rare diseases or mobility challenges." Bauman recently wrote a blog about five of the reasons electronic informed consent for clinical trials (eICF) matters to patients and clinical trial researchers. To read Baumann's blog, click  here For more information about OpenClinica's eConsent tool, see:

OpenClinica Frequently Asked Questions (FAQ)

  • When was OpenClinica founded?

    OpenClinica was founded in 2004.

  • Where is OpenClinica's headquarters?

    OpenClinica's headquarters is located at 1075 Main Street, Waltham.

  • What is OpenClinica's latest funding round?

    OpenClinica's latest funding round is Growth Equity.

  • Who are the investors of OpenClinica?

    Investors of OpenClinica include Thompson Street Capital Partners.

  • Who are OpenClinica's competitors?

    Competitors of OpenClinica include SignalPath and 1 more.


Compare OpenClinica to Competitors

Medrio Logo

Medrio provides electronic data capture software for the process of clinical research. The platform supports phase I-IV trials, outcomes research, registries, retrospective chart reviews, and other clinical study needs. It was founded in 2005 and is based in San Francisco, California.

Medidata Logo

Medidata provides web-based technology for streamlining the design, planning, and management of key aspects of the clinical development processes. It helps in protocol development, investigator benchmarking and budgeting, contract research organization benchmarking and budgeting, and the capture, management, analysis, and reporting of clinical trial data. It was founded in 1999 and is based in New York, New York. In October 2019, Medidata Solutions was acquired by Dassault Systemes.

Acceliant Logo

Acceliant provides real-time, integrated clinical trial solutions, CROs, pharma tools, and expertise to take intelligent and smarter decisions. Its eClinical Suite allows users to build studies, design case reports, capture data through multiple channels, and manage other clinical data management functions.

Clinical Ink Logo
Clinical Ink

Clinical Ink is a global life science company that focuses on data, technology, and patient-centric research in the clinical trials industry. The company offers a comprehensive eSource platform and clinical trial solutions, including Direct Data Capture, electronic Clinical Outcome Assessments (eCOA), eConsent, telehealth, neurocognitive testing, and digital biomarkers advancements, all designed to improve data precision and operational efficiency in clinical research. Clinical Ink primarily serves sponsors, Contract Research Organizations (CROs), researchers, and patients in the clinical trials industry. It is based in Horsham, Pennsylvania.

ConcertAI Logo

ConcertAI is a healthcare technology company. It uses artificial intelligence (AI) to help oncologists make more informed treatment decisions for their patients. The platform analyzes large datasets of clinical and genomic data to identify patterns and insights which is used for personalized cancer treatment. It was formerly known as Precision HealthAI. It was founded in 2017 and is based in Cambridge, Massachusetts.

Clinion Logo

Clinion provides an artificial intelligence (AI)-based e-clinical platform for clinical trial setup and management. Its platform consists of electronic data capture (EDC), randomization and trial supply management (IWRS/RTSM), patient-reported outcomes (eCOA), and clinical trial management systems (CTMS). The company offers its services to small and medium-sized contract research organizations (CROs), academic, and pharmaceutical organizations. It was founded in 2010 and is based in Austin, Texas.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.